Company intelligence / Profile preview

Beijing No. 1 Biochemical Pharmaceutical

Beijing, Beijing Shi, Chinaen.1bp.com.cn ↗

Ownership: Private
Development stage: Other

Overview

Beijing No. 1 Biochemical Pharmaceutical is a long-established Chinese pharmaceutical company specializing in the development, manufacturing, and sale of biochemical drugs such as spleen aminopeptide, thymosin, and thrombin—the first to be developed and produced domestically. The company has completed a Phase 4 clinical trial for spleen aminopeptide oral solution targeting seasonal allergic rhinitis in children.

Therapeutic areas: HematologyImmunology
Modalities: Small moleculeProtein
Industry: Biotech

Drug pipeline

2 assets

compound embryonic bovine liver extract

Unknown

1 more asset in the full pipeline.

Request access →

Partnerships

Received support from China Development Bank for development finance.

Beyond the preview

Go deeper on Beijing No. 1 Biochemical Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing No. 1 Biochemical Pharmaceutical.

Explore the full profile